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Abstract
Purpose Chronic lung inflammation commonly induces a
multitude of structural and functional adaptations within
the lung tissue and airspaces. Yet the impact of a persistent
inflammatory environment on alveolar macrophages is still
incompletely understood. Here, we examined morphology
and function of alveolar macrophages in a transgenic
mouse model of chronic lung disease.
Methods Imaging flow cytometry, flow cytometry, and
microscopic evaluation of alveolar macrophages isolated
from healthy and inflamed lungs were performed. Gene
expression of polarization markers was compared by
quantitative real-time RT-PCR. The pro-inflammatory
immune response of alveolar macrophages toward bacterial
ligands was assessed in in vivo clodronate-liposome
depletion studies.
Results Chronic lung inflammation is associated with a
substantially altered, activated alveolar macrophage mor-
phology, and blunted TNF-a response by these cells
following stimulation with ligands derived from the res-
piratory pathogen Streptococcus pneumoniae.
Conclusions These results demonstrate pleiotropic
effects of pulmonary inflammation on alveolar macro-
phage phenotype and function and suggest a functional
impairment of these cells during infection with airborne
pathogens.
Keywords Chronic lung disease  Inflammation 
Alveolar macrophage  Macrophage polarization  Infection
Introduction
Chronic lung diseases (CLDs) are multi-factorial inflam-
matory disorders and frequently involve alterations of
structural as well as hematopoietic cells in the airways. In
line with this, substantial molecular alterations of alveolar
macrophages (AMs) were described in asthma [1], chronic
obstructive pulmonary disease (COPD) [2], and fibrosis [3]
disease settings. Beyond their classical scavenger function,
AMs are dedicated pulmonary sentinels and shape host
defense via the initiation of a cytokine immune response
following recognition of pathogen-associated molecular
patterns (PAMPs). Notably, AMs (and other macrophage
populations) have a unique propensity to dynamically
adapt to the local microenvironment via polarization into
M1 or M2 phenotypes, which are associated with unique
physiological functions during inflammatory processes [4].
In recent years, it was shown by others that macrophage
polarization states are intimately linked to a unique mor-
phology [5] and that vice versa patterning of macrophages
into a distinct cell shape induces their polarization [6].
However, these observations were either made in in vitro
approaches and/or in a non-lung environment and a link
Andreas Jeron and Dunja Bruder have contributed equally to this
work.
& Julia De´sire´e Boehme
julia.boehme@helmholtz-hzi.de
1 Infection Immunology Group, Institute of Medical
Microbiology and Hospital Hygiene, Infection Control and
Prevention, Otto-von-Guericke University, Leipziger Straße
44, 39120 Magdeburg, Germany
2 Immune Regulation Group, Helmholtz Centre for Infection
Research, Inhoffenstraße 7, 38124 Brunswick, Germany
3 Department of Translational Inflammation Research, Institute
of Experimental Internal Medicine, Otto-von-Guericke





between morphology and function for macrophages is still
missing in respiratory inflammatory disorders.
In the present study, we aimed to elucidate the impact of
a persistent inflammatory environment on alveolar macro-
phage phenotype and function in vivo. To this end, we
utilized the SPC-HAxTCR-HA transgenic mouse model
previously established and extensively characterized in our
lab [7–9]. In these mice, the concomitant expression of a
neo-self antigen (influenza A/PR8 hemagglutinin, HA) by
alveolar epithelial cells and the generation of self-antigen
specific (HA-specific) CD4? T cells evokes the sponta-
neous development of chronic pulmonary inflammation.
We have previously demonstrated that chronic lung
inflammation in SPC-HAxTCR-HA mice is associated with
multifocal interstitial, perivascular, and peribronchial
lymphocytic infiltrations as well as the development of
alveolar emphysema and hemosiderosis [7]. Here, we
provide comparative morphological and functional analy-
ses between alveolar macrophages of single transgenic
SPC-HA (only pulmonary self-antigen expression; healthy
control group) and double-transgenic SPC-HAxTCR-HA
(pulmonary self-antigen expression and self-antigen
specific T cells; chronic lung disease) mice.
Materials and Methods
Mice
TCR-HA [10], SPC-HA [7], and SPC-HAxTCR-HA [7]
mice have been previously described. Mice were bred in
the animal facility at the Helmholtz Centre for Infection
Research in specific-pathogen-free (SPF) conditions and
were used at 12–24 weeks of age. All animal experiments
were performed according to national guidelines and were
approved by government institutions (Niedersa¨chsisches
Landesamt fu¨r Verbraucherschutz und Lebensmittel-
sicherheit, file no. 33.14-42505-04-14/1715).
Flow Cytometry and Imaging Flow Cytometry
Bronchoalveolar lavage (BAL) was performed by flushing
the lungs once with 1 mL PBS and BAL cells were
obtained by centrifugation. BAL cells were erythrocyte-
depleted by treatment with ACK buffer (0.15 mM NH4Cl,
1 mM KHCO3, 0.1 mM EDTA, pH 7.2–7.4), Fcc-receptors
were blocked with anti-CD16/CD32 (clone: 93); cells were
stained with anti-F4/80 (clone: BM8) and anti-CD11c
(clone: N418, all BioLegend). In flow cytometry, single
cells were analyzed using a LSR Fortessa flow cytometer
(BD Biosciences). Alveolar macrophages (AMs) were
identified as F4/80? and—where indicated—CD11c?,
autofluorescencehigh, forward scatterhigh, and side
scatterhigh cells. Autofluorescence signals were detected in
FITC channel (500–550 nm). In imaging flow cytometry,
alveolar macrophages were identified as F4/80? and
CD11c?. To exclude T cells from morphological analyses
in imaging flow cytometry, cell suspensions were addi-
tionally stained with antibody against CD3 (clone:
145-2C11, eBioscience). Alveolar macrophages were ana-
lyzed by applying the image-based features intensity, area,
and bright detail intensity on the SSC-channel. Analyses
were conducted using a FlowSight System (920 magnifi-
cation, Amnis, part of EMD Millipore) Inspire acquisition
software and IDEAS software version 6.0.
Panoptic Staining with Pappenheim Method
For analyses of alveolar macrophage phenotype, BAL cells
from SPC-HA and SPC-HAxTCR-HA mice were isolated
and erythrocyte-depleted as described above. Cells were
spun (800 rpm, 15 min, RT) onto SuperFrost glass slides
(Thermo Scientific), air dried, and stained with May-
Gru¨nwald and Giemsa reagent (both Merck). Slides were
washed and air dried, and samples were covered with Neo-
Mount (Merck) reagent and sealed by glass cover slips.
Images were captured at 639 oil immersion objective
using an Axio Imager Z2 microscope equipped with
AxioCam MRc5 and ZEN software (both Carl Zeiss
Microscopy GmbH).
In Vivo Experiments
For in vivo bacterial stimulation experiments, a pneumo-
coccal serotype 4 strain (S.pneumoniae TIGR4, ATCC
BAA-334 [11] ) was used. Pneumococci were grown
overnight on Columbia blood agar plates (BD) at 37 C
and 5 % CO2, single colonies were resuspended and cul-
tured in Todd-Hewitt broth & yeast extract to mid-loga-
rithmic phase (OD600nm 0.3–0.5), washed, and diluted in
PBS to the desired concentration. CFUs were determined
by growing serial dilutions of the inoculums on blood agar
plates. Bacterial suspension was spun down (17,9009g),
the supernatant was removed, and the bacterial pellet was
resuspended in ice-cold ethanol (70 % v/v) and incubated
at 4 C for 1 h. The bacterial suspension was again spun
down, and the pellet was resuspended in 1 mL sterile PBS/
Glycerol solution (25 % v/v). Plating after ethanol treat-
ment was carried out to verify effective bacterial killing.
Ethanol-killed bacterial suspensions were stored at -70 C
until further use. Mice were anesthetized by intraperitoneal
injection of ketamine/xylazine, and 20 lL of bacterial
suspension—equivalent to 106 CFU—was oropharyngeally
administered. Mice were sacrificed at 4 h post-adminis-
tration, and BAL was performed by flushing the lungs with
1 mL PBS. In order to deplete alveolar macrophages,
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50 lL of clodronate-liposomes (=250 lg encapsulated
clodronate, purchased from ClodLip BV) was oropharyn-
geally administered to mice 3 days before treatment with
ethanol-killed pneumococcal suspensions.
Purification of Alveolar Macrophages
BAL cells were erythrocyte-depleted and incubated in
DMEM (Gibco, supplemented with 10 % fetal bovine
serum and antibiotics) for 90 min at 37 C, 5 % CO2 in
bacteriological plastic petri dishes. Non-adherent cells
were then removed by extensively rinsing the surface with
PBS. To verify effective purification, adherent cells were
detached by treatment with 0.05 % Trypsin/EDTA
(Gibco), stained with antibodies against F4-80 and CD11c
and analyzed by flow cytometry. For RNA analysis,
adherent cells were directly lysed on the plastic surface by
treatment with RLT buffer (Qiagen, supplemented with
1 % mercaptoethanol), and RNA extraction protocol was
applied. RNA was extracted and purified using RNeasy
Mini and RNase-free DNase kit (both Qiagen) according to
the manufacturer’s instructions.
Quantitative Real-Time RT-PCR
For gene expression analyses of purified alveolar macro-
phages, RNA was analyzed using the SensiFASTTM
SYBR No-ROX One-Step Kit (Bioline) according to the
manufacturer’s instructions. Transcript levels were nor-
malized to the housekeeping gene Actb. Following primer
sequences were used: Actb, 50-CTTCTTTGCAGCTCC
TTCGT-30 (forward) and 50-TCCTTCTGACCCATTCC
CAC-30 (reverse); Msr1, 50-GGAATAAGAGGTATTCCA
GGTG-30 (forward) and 50-TTTGTCCTTTAGGTCCAG
GAG-30 (reverse); Fizz1, 50-ACGAGTAAGCACAGGCA
GTT-30 (forward) and 50-TGCCAATCCAGCTAACTAT
CCC-30 (reverse).
Enzyme-Linked Immunosorbent Assay (ELISA)
For detection of TNF-a in BAL fluid, the Mouse TNF-a
ELISA MAXTM Standard kit (BioLegend) was used
according to the manufacturer’s instructions.
Statistical Analyses and Artwork
Statistical evaluation and figure design was performed
using Graph Pad Prism Software. Unpaired, two-tailed
Mann–Whitney-test was chosen to compare two groups.
For comparison of multiple groups, one-way or two-way
ANOVA followed by Bonferroni post-test was applied.
Results
Altered Fluorescence Characteristics and Cellular
Texture of Alveolar Macrophages in CLD
For a primary characterization of the AM phenotype in
chronic lung inflammation, these cells were recovered from
SPC-HA and SPC-HAxTCR-HA mice by BAL and were
subjected to morphologic analyses by conventional flow
cytometry (FACS) as well as imaging flow cytometry.
FACS analyses revealed AMs from diseased SPC-
HAxTCR-HA mice to have significantly smaller size
compared to AMs from healthy SPC-HA control mice—
indicated by reduced forward scatter (FSC) properties.
Moreover, quantification of autofluorescence—an intrinsic
characteristic of alveolar macrophages—yielded signifi-
cantly reduced indices for AMs from SPC-HAxTCR-HA
mice (Fig. 1a). In imaging flow cytometry, these cells
displayed altered cytoplasmic signals reflected by alter-
ations of side scatter (SSC) characteristics (Fig. 1b, c),
indicating a markedly changed cellular texture of alveolar
macrophages in a persistent inflammatory pulmonary
environment.
Activated Phenotype of Alveolar Macrophages
in Murine CLD
Further comparative morphologic analyses of alveolar
macrophages were conducted using Pappenheim-stained
cytospin samples of bronchoalveolar lavage fluid cells
from SPC-HA and SPC-HAxTCR-HA mice. Microscopic
evaluation demonstrated AMs from diseased SPC-
HAxTCR-HA mice to display an activated phenotype,
specified by increased formations of membrane protrusions
(Fig. 2, see black arrows).
Together, the observed morphologic alterations provide
first evidence for an impact of chronic pulmonary inflam-
mation on alveolar macrophages and establish a basis for
further investigations regarding functional alterations of
AMs in murine lung disease.
M2 Signature of Alveolar Macrophages in Murine
CLD
Inflammatory conditions in multiple infectious as well as
non-infectious disease settings are intimately linked to
macrophage polarization into classically activated M1 or
alternatively activated M2 phenotypes [12, 13]. In order to
elucidate the impact of CLD on AM polarization status,
BAL cells from SPC-HA and SPC-HAxTCR-HA mice
were isolated and AMs were purified by adhesion. This
method allowed for the fast and efficient isolation of highly
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pure (*95 %) alveolar macrophages (Fig. 3a). Compara-
tive gene expression analyses of macrophage polarization
markers were conducted by quantitative real-time RT-PCR.
Here, up-regulation of the gene encoding for macrophage
scavenger receptor 1 (Msr1, fold change 5.5) and Resistin-
like molecule alpha1 (Fizz1, fold change 16.1), both
molecules are known to be overrepresented in M2 macro-
phages, was observed (Fig. 3b).
Alveolar Macrophages in Murine CLD are
Hyporesponsive to Stimulation with Bacterial
Ligands
Following recognition of respiratory pathogens, alveolar
macrophages mount a pro-inflammatory immune response
by secreting (among other mediators) TNF-a. This step is
critical for the rapid elimination of microbial threats but, on
the other hand, involves the risk to develop immune
pathology at the expense of lung tissue integrity. In order to
test a possible influence of chronic lung inflammation on
alveolar macrophage functionality, SPC-HAxTCR-HA
mice and healthy controls were oropharyngeally inoculated
with ethanol-killed Streptococcus pneumoniae TIGR4, and
the early airway inflammatory response was quantified by
assessing TNF-a levels in BAL fluid (BALF) at 4 h fol-
lowing administration. As expected, bacterial stimulation
led to an early and robust cytokine response in the airways
of healthy SPC-HA mice (Fig. 4a). Strikingly, TNF-a
levels were *60 % decreased in the diseased SPC-
HAxTCR-HA group. In order to verify that this blunted
inflammatory response was mediated by alveolar macro-
phages, these cells were depleted by oropharyngeal
administration of clodronate-liposomes (ClodLip) 3 days
prior bacterial stimulation. Clodronate treatment led to a
75 % reduction of viable AMs (Mean ± SEM AM counts
PBS-group vs. ClodLip group: 25383 ± 6040 vs.
6330 ± 1536) within 3 days, whereas the single adminis-
tration of control liposomes (PBS-Lip) or carrier solution
(PBS) had no effect on alveolar macrophage numbers
(Fig. 4b). Notably, TNF-a levels following bacterial stim-
ulation in AM-depleted mice were substantially reduced
and close to detection limit in both mouse groups. This
validates AMs to be the main early airway TNF-a source
following pneumococcal stimulation and, more impor-
tantly, suggests a functional impairment of AMs in chronic
lung disease.
Discussion
In the present study, we aimed to dissect the impact of
chronic lung disease on the alveolar macrophage pheno-
type. To this end, we utilized the SPC-HAxTCR-HA
transgenic mouse model for T cell-mediated lung inflam-
mation. Despite different etiologies, a participation of
lymphocyte immune responses has been suggested for the
pathogenesis of several lung disorders such as COPD [14]
or sarcoidosis [15] and SPC-HAxTCR-HA lungs pheno-
copy [7] histopathological manifestations of human CLD,
e.g., airway remodeling and lymphocytic infiltrations.
Fig. 1 Flow cytometric analyses of AM morphology in healthy and
diseased lungs. a BAL cells from SPC-HA (n = 6) and SPC-
HAxTCR-HA (n = 6) mice were analyzed by FACS; AMs were
identified as FSChighSSChighF4-80?autofluorescencehigh cells. Rela-
tive FSC and autofluorescence were calculated by median fluores-
cence intensity (MFI) of individual sample/mean MFI of the SPC-HA
(healthy) control group. Representative histogram depicts autofluo-
rescent signal intensities of AMs from SPC-HA (gray shaded) versus
SPC-HAxTCR-HA (dashed line) mice and their respective MFI (see
numbers). b BAL cells from SPC-HA (n = 5) and SPC-HAxTCR-HA
(n = 6) mice were analyzed by imaging flow cytometry (analyzed
SSC-parameters: intensity, area, bright detail intensity); AMs were
identified as F4-80?CD11c?CD3- cells. Statistical analyses were
performed by using unpaired, two-tailed Mann–Whitney-test.
*p\ 0.05, **p\ 0.01 c Representative images from imaging flow
cytometer FlowSight of alveolar macrophages from SPC-HA and
SPC-HAxTCR-HA mice, PB pacific blue
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By using fluorescence-based cytometric assays, we
detected several important morphological changes of
alveolar macrophages in our in vivo model. In detail, we
show that their size, structural, and intrinsic fluorescence
properties are significantly affected within an inflammatory
environment. Interestingly, alterations in airway macro-
phage SSC and autofluorescence have also been reported in
another study in SHIP1 (an inositol polyphosphate-5-
phosphatase)-deficient mice, that spontaneously develop
severe lung inflammation associated with a pathologic M2-
macrophage phenotype [16]. These findings are of general
interest for two reasons. First, FACS technology provides a
valuable and commonly utilized tool to characterize
inflammatory processes on airway mucosal surfaces. Yet
the massive autofluorescence signals of airway macro-
phages within, e.g., FITC, PE, and PerCp detectors require
well-considered panel design and the utilization of addi-
tional control stainings to correctly separate large intrinsic
(false) from antibody-derived (true) fluorescence signals.
Since we and others have proven fundamental differences
of AM fluorescence properties in healthy versus pathologic
conditions, it is likely to observe similar effects in other
non-infectious and infectious respiratory disease settings.
In practice, this would adversely affect accuracy of, e.g.,
cell surface molecule quantitation. Thus, for similar studies
using comparative flow cytometric investigations on air-
way macrophages, the aforementioned effects should def-
initely be considered. Second, information on the
mentioned parameters offers a simple additive tool to
characterize the alveolar macrophage phenotype in more
detail and to detect morphologic alterations that possibly
hint to molecular and functional cellular adaptations.
Accordingly, we could provide a link between affected
fluorescent properties and activation, polarization, and
functional alterations in alveolar macrophages in CLD.
Here, the blunted AM-dependent TNF-a response toward
Fig. 2 Analyses of AM
morphology in healthy and
diseased lungs by light
microscopy. Cytospins from
BAL samples from SPC-HA
and SPC-HAxTCR-HA were
stained with May-Gru¨nwald and
Giemsa reagent (Pappenheim
method), and cell morphology
was analyzed by light
microscopy. Representative
images of alveolar macrophages
from n = 4 mice/group at 963
magnification are depicted.
Scale bar 10 lm. Black arrows
indicate membrane protrusions
Fig. 3 Analyses of purified AMs from healthy versus diseased lungs
by quantitative real-time RT-PCR. a AMs from erythrocyte-depleted
BAL cell suspensions were purified by adhesion (90 min, 37 C) on
bacteriological plastic, detached by trypsin–EDTA treatment, and
purity was analyzed by FACS. Left square exemplarily depicts
percentages of AMs (CD11chigh, F4-80high) of analyzed singlets in
non-purified BAL samples from SPC-HAxTCR-HA mice. Right
square depicts AM percentages of BAL cells from SPC-HAxTCR-
HA mice after purification. Note the decreased abundance of the
surface molecule CD11c on AMs after trypsin–EDTA treatment.
b Purified alveolar macrophages from SPC-HA and SPC-HA xTCR-
HA mice were pooled (n = 3–5 mice/group), RNA was extracted,
and relative expression of indicated transcripts was determined. Gene
expression was normalized to the SPC-HA control group
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Gram-positive bacterial ligands in SPC-HAxTCR-HA air-
ways suggests a functional impairment of these cells during
infection with airborne pathogens. Of note, TNF-a was
shown to exert protective efficacy in several models of
respiratory infection [17–20]. In detail, this cytokine acts
on macrophages as well as neutrophils by enhancing
phagocytosis of opsonized bacteria and antibody-depen-
dent cytotoxicity [21, 22]. On the other hand, it was pre-
viously demonstrated that lung-specific overexpression of
TNF-a in mice was linked to a disease phenotype mirroring
hallmark features of emphysema and pulmonary fibrosis
[23]. In this context, macrophages from pre-diseased
human and murine lungs were found to mount blunted
cytokine responses upon stimulation with bacterial ligands
[24, 25]. It is speculated that this airway hyporesponsive-
ness provides an advantage to the host by evading PAMP-
induced immunopathology that would further compromise
tissue integrity in the pre-inflamed lung. However, given
the two faces of TNF-a (and other pro-inflammatory
molecules) in alveolar macrophage-mediated immune
responses, further studies will be needed to explore their
role on the shape of antibacterial host defense in the pre-
diseased lung.
Conclusion
Using a model of chronic lung disease, we provide a link
between phenotypical changes in alveolar macrophages to
distinct functional alterations. We further plan to charac-
terize the alveolar macrophage phenotype in more detail
and aim to elucidate the functional role of these adaptations
on pulmonary immunity.
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